Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform
- PMID: 22085491
- DOI: 10.1016/j.canlet.2011.11.009
Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform
Abstract
Current cancer therapeutics are identified based on initial tumor regression screens that mostly kill differentiated tumor cells, sparing the rare cancer stem cells (CSCs). Being rare and difficult to characterize, it remains a challenge to identify compounds active against them. Side population (SP) cells identified in multiple cancer cell line panels expressing mitochondrial Cytochrome C-EGFP were evaluated for identifying possible drug candidates utilizing high-throughput imaging. We identified heat shock protein 90 inhibitors as potential agents to sensitize SP cells to anticancer drugs. Hsp90 inhibitors induced down regulation of Akt leading to proteasomal degradation of survivin and consequent mitochondrial apoptosis. A successful screening platform for identifying compounds targeting drug resistant side population cells was developed.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.Cancer Res. 2006 Feb 1;66(3):1783-91. doi: 10.1158/0008-5472.CAN-05-3692. Cancer Res. 2006. PMID: 16452239
-
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.Cancer Chemother Pharmacol. 2010 Aug;66(3):535-45. doi: 10.1007/s00280-009-1194-3. Epub 2009 Dec 13. Cancer Chemother Pharmacol. 2010. PMID: 20012863
-
Characterization of side population cells in human malignant mesothelioma cell lines.Lung Cancer. 2010 Nov;70(2):146-51. doi: 10.1016/j.lungcan.2010.04.020. Epub 2010 May 20. Lung Cancer. 2010. PMID: 20493579
-
Side population cells as prototype of chemoresistant, tumor-initiating cells.Biomed Res Int. 2013;2013:517237. doi: 10.1155/2013/517237. Epub 2013 Nov 4. Biomed Res Int. 2013. PMID: 24294611 Free PMC article. Review.
-
Side population.Methods Mol Biol. 2015;1293:73-81. doi: 10.1007/978-1-4939-2519-3_4. Methods Mol Biol. 2015. PMID: 26040682 Review.
Cited by
-
Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity.Oncotarget. 2017 Mar 21;8(12):19323-19341. doi: 10.18632/oncotarget.14252. Oncotarget. 2017. PMID: 28038472 Free PMC article.
-
Heat Shock Proteins Promote Cancer: It's a Protection Racket.Trends Biochem Sci. 2016 Apr;41(4):311-323. doi: 10.1016/j.tibs.2016.01.003. Epub 2016 Feb 11. Trends Biochem Sci. 2016. PMID: 26874923 Free PMC article. Review.
-
Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy.Discov Med. 2013 Mar;15(82):188-94. Discov Med. 2013. PMID: 23545047 Free PMC article.
-
Heat shock proteins-driven stress granule dynamics: yet another avenue for cell survival.Apoptosis. 2021 Aug;26(7-8):371-384. doi: 10.1007/s10495-021-01678-w. Epub 2021 May 12. Apoptosis. 2021. PMID: 33978921 Review.
-
A high-throughput real-time in vitro assay using mitochondrial targeted roGFP for screening of drugs targeting mitochondria.Redox Biol. 2019 Jan;20:379-389. doi: 10.1016/j.redox.2018.10.013. Epub 2018 Oct 24. Redox Biol. 2019. PMID: 30408753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
